HSA — authorised 30 January 2004
- Marketing authorisation holder: BOEHRINGER INGELHEIM
- Status: likely_approved
HSA authorised Spiriva on 30 January 2004
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 30 January 2004.
BOEHRINGER INGELHEIM holds the Singaporean marketing authorisation.